These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 17918451

  • 21. [Effection of compositie salviae dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome].
    Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL.
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):440-3. PubMed ID: 17511155
    [Abstract] [Full Text] [Related]

  • 22. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
    Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
    [Abstract] [Full Text] [Related]

  • 23. [Clinical observation on prevention of "jia wei si jun zi tang" from damage of hepatic reserving function after intervention of liver cancer].
    Zhang B, Huang G, Zhang Y, Chen X, Hu P, Xu B.
    Zhong Yao Cai; 2004 May; 27(5):387-9. PubMed ID: 15376398
    [Abstract] [Full Text] [Related]

  • 24. [Effects of prostaglandin E1 on hepatic function and hepatofibrosis in patients with chronic hepatitis B].
    Gong HY, Wang KQ, Tang SG, Zhang WJ.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct 28; 26(5):445-7. PubMed ID: 12536496
    [Abstract] [Full Text] [Related]

  • 25. Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis.
    Wang HY, Cheng ML.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 28; 7(2):179-84. PubMed ID: 18397855
    [Abstract] [Full Text] [Related]

  • 26. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats.
    Mu Y, Liu P, Du G, Du J, Wang G, Long A, Wang L, Li F.
    J Ethnopharmacol; 2009 Jan 12; 121(1):35-42. PubMed ID: 18996463
    [Abstract] [Full Text] [Related]

  • 27. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
    Chen H, Weng L.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr 12; 20(4):255-7. PubMed ID: 11789260
    [Abstract] [Full Text] [Related]

  • 28. [Relationship between liver mass and soluble intercellular adhesion molecule-1 in patients with liver cirrhosis].
    Li J, Wen H, Li SG, Yang QX, Yang LF, Wu TT, Lai LX, Lü HW.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep 12; 25(9):1175-7. PubMed ID: 16174593
    [Abstract] [Full Text] [Related]

  • 29. [Clinical study of method of strengthening body resistance and disintoxication disintoxication in patients with HCC of post-TACE].
    Chen ZX, Zhang SJ, Hu HT, Sun BG, Yin LR.
    Zhongguo Zhong Yao Za Zhi; 2007 Jun 12; 32(12):1211-3. PubMed ID: 17802890
    [Abstract] [Full Text] [Related]

  • 30. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM, Abu-Zekri NB.
    Int J Surg; 2008 Oct 12; 6(5):362-6. PubMed ID: 18662898
    [Abstract] [Full Text] [Related]

  • 31. [Experimental study on the anti-liver fibrosis effect of guzhang tablet in rats].
    Zhao YY, Liu FZ, Yang XP.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec 12; 23(12):922-5. PubMed ID: 14714366
    [Abstract] [Full Text] [Related]

  • 32. [Clinical study of treatment nonalcoholic fatty liver with qianggan capsule].
    Chen ZX, Zhang SJ, Yun LR.
    Zhongguo Zhong Yao Za Zhi; 2006 Oct 12; 31(20):1739-41. PubMed ID: 17225548
    [Abstract] [Full Text] [Related]

  • 33. [Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
    Guo JX, Ma HB, Li YL, Xu J, Yang LH, Shi JB, Li B, Liu AX, Li XX, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb 12; 23(1):71-3. PubMed ID: 19799025
    [Abstract] [Full Text] [Related]

  • 34. [Effects of cordyceps sinensis on T lymphocyte subsets and hepatofibrosis in patients with chronic hepatitis B].
    Gong HY, Wang KQ, Tang SG.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun 28; 25(3):248-50. PubMed ID: 12212155
    [Abstract] [Full Text] [Related]

  • 35. [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].
    Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J.
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul 28; 1(2):89-98, 102. PubMed ID: 15339577
    [Abstract] [Full Text] [Related]

  • 36. Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis.
    Li CH, Pan LH, Yang ZW, Li CY, Xu WX.
    World J Gastroenterol; 2008 Jun 14; 14(22):3569-73. PubMed ID: 18567088
    [Abstract] [Full Text] [Related]

  • 37. Effect of sea buckthorn on liver fibrosis: a clinical study.
    Gao ZL, Gu XH, Cheng FT, Jiang FH.
    World J Gastroenterol; 2003 Jul 14; 9(7):1615-7. PubMed ID: 12854177
    [Abstract] [Full Text] [Related]

  • 38. [Intervention of chronic hepatitis B liver fibrosis patients in different stages by syndrome typing and different activating blood removing stasis methods: a clinical study].
    Liu SY, Zhang YQ, Liu YL, Guo P, Zhou CM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov 14; 33(11):1457-61. PubMed ID: 24483103
    [Abstract] [Full Text] [Related]

  • 39. [Clinical and experimental study on anti-liver fibrosis effect of xuelong granule].
    Li ZZ, Wang X, Sui ZY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Nov 14; 21(11):813-5. PubMed ID: 12575371
    [Abstract] [Full Text] [Related]

  • 40. [Clinical and experimental study on wuling pill in treating gestation period intrahepatic cholestasis].
    Shi DY, Chen H, Tian XY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Feb 14; 26(2):114-8. PubMed ID: 16548349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.